Since in most female G6PD mutation carriers, hemolysis does not occur spontaneously but can be provoked by infection or drugs with oxidizing properties, e.g., most of the antimalarial agents, some sulfur drugs, and urinary antibiotics, it might be advisable to screen for G6PD activity before prescribing oxidative drugs to women over 60 [195]. The gene discussed is G6PD; the disease is infection.